上世纪末曾有人提出我国的中药产业将成为本世纪的“朝阳产业”,口号甚是鼓舞人心。但结合我国中药产业的现状分析,却不容乐观。想在本世纪的头几年达到蓬勃兴盛的状态可能还有很大差距。问题在哪里,笔者以为,除了中药生产企业本身存在诸多问题外,关键还在于针对中药学本身的现代研究没有取得明显的突破性进展。以致我国有关中药研发的政策、法 At the end of the last century, it was suggested that the Chinese medicine industry in China will become the “sunrise industry” in this century. The slogan is very encouraging. However, with the analysis of the status quo of China’s traditional Chinese medicine industry, it is not optimistic. There may be a big gap in the hope of reaching a thriving state in the first few years of this century. Where the problem lies, the author believes that, apart from the many problems existing in the Chinese medicine manufacturing enterprises themselves, the key is still that there has been no significant breakthrough in the modern research on Chinese pharmacy itself. As a result, China’s policies and laws on R&D of Chinese medicine